IR, defined as reduced or impaired insulin sensitivity in insulin-dependent tissues or organs manifested by impaired glucose uptake and oxidation (6), is an important risk factor for the development of type 2 diabetes and CHD. The gene discussed is INS; the disease is type 2 diabetes mellitus.